Abstract
Malignant Fibrous Histiocytoma (MFH) of bone is a relatively recently recognized entity. After the initial reports in the early 70 s [1], this entity became well established in the pathology and clinical literature by the late 70 s [2–4]. The age distribution is variable, patients are generally older than those with osteosarcoma, and there seems to be a slight predilection for males [5]. The skeletal distribution is also variable, with a predilection for the metaphyses of long bones [6]. Radiologically, it manifests as an aggressive radiolucent defect with ill-defined margins and often, an associated soft-tissue mass. Histologically, it shows striking resemblance to MFH arising in soft tissues. Not infrequently, it constitutes the high grade component of a de-differentiated chondrosarcoma, which has a relatively poorer prognosis. It often is a component of osteosarcomas, and histologically, the only major difference between a fibroblastic osteosarcoma and an MFH is the presence or absence of osteoid. In our experience at the UT MD Anderson Cancer Center, we have seen 2 patients, 1 of them reported in this series, where the initial biopsy and the final surgical specimen diagnosis was felt to be an MFH, but the metastatic disease that developed at a later date unequivocally demonstrated osteoid, making us hypothesise, that MFH of bone may indeed be a variant of fibroblastic osteosarcoma with no demonstrable osteoid initially, however it can manifest at a later date.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Feldman F, Norman D (1972) Intra- and extraosseous malignant histiocytoma (malignant fibrous xanthoma). Radiology 104: 497–508
Spanier SS, Enneking WF, Enriquez P (1975) Primary malignant fibrous histiocytoma of bone. Cancer 36: 2084–2098
Huvos AG (1976) Primary malignant fibrous Histiocytoma of bone. Clinicopathologic study of 18 patients. NY State J Med 76: 552–559
Dahlin DC, Unni KK, Matsuno T (1977) Malignant fibrous histiocytoma of bone. Fact or fancy. Cancer 39: 1508–1516
Dahlin DC, Unni KK (1986) Malignant fibrous histiocytoma. In: Bone tumors. Charles C Thomas, Springfield, p 358
Chawla SP, Benjamin RS, Abdul-Karim FW, Ayala AG, Papadopoulos NEJ, Plager C, Romsdahl M, Jaffe N, Murray JA (1984) Adjuvant chemotherapy of primary malignant fibrous histiocytoma of bone-Prolongation of disease free and overall survival. In: Jones SE and Salmon SE (eds) Adjuvant Chemotherapy of Cancer IV. Grune and Stratton, New York, pp. 621–629
Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fanning CV, Grice B, Armen T, Plager C, Papadopoulos NEJ, Edeiken J, Wallace S, Jaffe N, Murray JA, Benjamin RS (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Sem Diag Path 4: 212–236
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag France
About this paper
Cite this paper
Patel, S.R. et al. (1994). Primary chemotherapy in malignant fibrous histiocytoma of bone — Updated UTMD Anderson Cancer Center Experience. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_123
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0765-2_123
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0767-6
Online ISBN: 978-2-8178-0765-2
eBook Packages: Springer Book Archive